Deep transcranial magnetic stimulation for obsessive compulsive disorder. (2nd October 2020)

• Record Type: Journal Article
• Authors: McCathern, Alexis G.; Mathai, David S.; Cho, Raymond Y.; Goodman, Wayne K.; Storch, Eric A.
• Is Part Of: Expert review of neurotherapeutics. Volume 20:Number 10(2020)
• Page Start: 1029
• Page End: 1036
• Publication Date: 2020-10-02
• Subjects: dtms -- OCD -- psychiatry -- treatment-resistant OCD -- neurophysiology; Neuropharmacology -- Periodicals; 615.7805
• DOI: 10.1080/14737175.2020.1798232
• Languages: English
• ISSNs: 1473-7175

Abstract

ABSTRACT: Introduction: Obsessive-compulsive disorder (OCD) is a common psychiatric disorder that can be chronic and debilitating if not properly treated. Current first-line treatments for OCD include cognitive-behavioral therapy with exposure and response prevention and serotonin uptake inhibitor medications; however, these therapies are not effective for all individuals. Areas covered: Deep transcranial magnetic stimulation (dTMS) has been hypothesized to be an effective alternative for individuals with treatment-resistant OCD. dTMS has thought to be favorable due to its low side effect profile and its minimally invasive nature. Expert opinion: This review evaluates the current research on effectiveness of dTMS therapy for individuals with treatment-resistant OCD. This review also investigates shortcomings in current dTMS research and the hypothesized future of dTMS therapy.